膝下动脉慢性完全闭塞性病变经皮腔内治疗的中期疗效观察

Midterm outcomes of percutaneous endovascular treatment for below-the-knee chronic total occlusion

  • 摘要:
      背景   经皮腔内血管成形(percutaneous transluminal angioplasty,PTA)治疗膝下动脉慢性完全闭塞性病变的有效性临床证据有限,治疗要点目前还不明确。
      目的   探讨膝下动脉慢性完全闭塞性病变经皮腔内血管成形治疗的中期临床疗效及治疗要点。
      方法   选取沈阳市第二中医医院周围血管科2019年1月- 2020年1月收治的18例膝下动脉慢性完全闭塞性病变患者临床资料,分析手术治疗经过、术前及术后相关临床症状体征、溃疡坏疽程度、辅助检查及血管通畅情况等。
      结果   18例患者中10例男性、8例女性;年龄(65.5±5.53)岁;PTA治疗后随访24周。术后2周治愈10例、显著5例、好转2例、无变化1例、恶化0例,有效率94.4%。15例术后血管通畅,皮温增高、踝肱指数(ankle brachial index,ABI)好转,手术成功率83.3%。2例病变周围建立了滋养血管,临床症状好转。1例开通血管失败,临床症状无变化经胫腓骨截肢。术前术后Rutherford及Wagner分级随时间变化,术后值较术前降低显著,差异有统计学意义(P<0.05)。PTA术后2~4周内溃疡愈合2例,转变为干性坏疽2例;4~8周内3例截趾平面清晰采取截趾(部分足、趾)手术(1例干性坏疽二次手术),切口愈合良好,均较PTA治疗前预截肢平面降低,保肢率94.4%。术后12周再狭窄率20%,经再次PTA治疗获得二期通畅。术后12周与24周一期通畅率均为80%;二期通畅率均为100%。
      结论   经皮腔内血管成形治疗膝下动脉慢性完全闭塞性病变安全有效。

     

    Abstract:
      Background   There are limited evidences regarding the clinical effect of percutaneous transluminal angioplasty (PTA) in the treatment of below-the-knee chronic total occlusion, and the key points of treatment remain unclear.
      Objective   To investigate the midterm clinical effect and key points of PTA in the treatment of below-the-knee chronic total occlusion.
      Methods   A retrospective analysis was performed for the clinical data about 18 patients with below-the-knee chronic total occlusion who were admitted to the department of peripheral vascular disease, Shenyang Second Hospital of Traditional Chinese Medicine from January 2019 to January 2020, and related data were analyzed, including the process of surgical treatment, clinical symptoms and signs before and after surgery, severity of ulcer and gangrene, auxiliary examination, and vascular patency.
      Results   Among the 18 patients, there were 10 male patients and 8 female patients, with a mean age of 65.5 ± 5.53 years, and all patients were followed up for 24 weeks after PTA. At 2 weeks after PTA treatment, 10 patients were cured, 5 had marked response, 2 had improvement, 1 had no change, and no patient had deterioration, with a response rate of 94.4%. After surgery, 15 patients achieved revascularization, an increase in skin temperature, and an improvement in ankle-brachial index, and the success rate of surgery was 83.3%. Nourishing vessels were established around the lesions for 2 patients, who had improved clinical symptoms. One patient experienced failure in revascularization and had no change in clinical symptoms, thus trans tibiofibular amputation was performed. Rutherford class and Wagner grade changed over time and decreased significantly after surgery (P<0.05). Within 2-4 weeks after PTA, 2 patients achieved ulcer healing, and ulcers transformed into dry gangrene in 2 patients; within 4-8 weeks after PTA, 3 patients with clear amputation level underwent partial amputation of feet or toes (a second surgery was performed for 1 patient with dry gangrene) and achieved good incision healing and a reduction in amputation level. The limb salvage rate was 94.4%. The restenosis rate was 20% at 12 weeks after PTA, and secondary patency was obtained after PTA treatment again. At 12 and 24 weeks after surgery, the primary patency rate was both 80%, and the secondary patency rate was both 100%.
      Conclusion   PTA is a safe and effective method for the treatment of below-the-knee chronic total occlusion.

     

/

返回文章
返回